0001209191-20-026891.txt : 20200504 0001209191-20-026891.hdr.sgml : 20200504 20200504173221 ACCESSION NUMBER: 0001209191-20-026891 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200430 FILED AS OF DATE: 20200504 DATE AS OF CHANGE: 20200504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANTINI GINO CENTRAL INDEX KEY: 0001276038 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 20846034 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-30 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001276038 SANTINI GINO C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 1 0 0 0 Ordinary Shares 2020-05-02 4 M 0 15390 A 45549 I By Trust Ordinary Shares 2020-05-02 4 F 0 6041 35.62 D 39508 I By Trust Restricted Stock Units 2020-04-30 4 A 0 11098 0.00 A 2021-04-30 2021-04-30 Ordinary shares 11098 11098 D Restricted Stock Units 2020-05-02 4 M 0 15390 0.00 D Ordinary shares 15390 0 D Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. On May 2, 2019, the reporting person was granted 15,390 restricted stock units, vesting in full on the first anniversary of the grant date. /s/ Miles W. McHugh, Attorney-in-Fact 2020-05-04